Multiple sclerosis (MS) as a chronic, degenerative autoimmune disease of the central
nervous system has a longitudinal and heterogeneous course with increasing treatment …

Background Developing a multiple sclerosis (MS) registry system in some countries has
helped to recognize better and monitor the disease. This study was aimed to compare global …

The management and treatment of multiple sclerosis (MS) is becoming more and more
complex as many medications are now available, with different routes of administration …

Background The detailed data concerning multiple sclerosis (MS) epidemiology in Poland
are based on studies from few and less populated provinces. Therefore, we evaluated MS …

Abstract Introduction Multiple Sclerosis (MS) as one of the most common causes of disability
around the world requires a uniform standardized information registry system to help policy …

Aim of study. The aim of this study was to collect and analyse data on relapsing-remitting
multiple sclerosis (RRMS) patients receiving disease-modifying therapies (DMTs) in Poland …

At two meetings of a Central European board of multiple sclerosis (MS) experts in 2018 and
2019 factors influencing daily treatment choices in MS, especially practice guidelines …

A patients Because of the past 3 decades' extensive research, several disease modifying
therapies became available, thus a paradigm change is multiple sclerosis care was …

Secondary progressive multiple sclerosis (SPMS) is a debilitating condition characterized by
gradual worsening after an initial relapsing disease course. Despite the recent advances in …

Background The demographics and management of patients with multiple sclerosis (MS)
differ across geographical regions, but it is unclear whether/how these differences affect …